A detailed history of Dafna Capital Management LLC transactions in Alector, Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 912,928 shares of ALEC stock, worth $4.26 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares
912,928
Previous 912,928 -0.0%
Holding current value
$4.26 Million
Previous $5.5 Million 24.59%
% of portfolio
1.06%
Previous 1.32%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$5.69 - $8.08 $1.72 Million - $2.45 Million
303,023 Added 49.68%
912,928 $5.5 Million
Q4 2023

Feb 14, 2024

SELL
$3.77 - $8.39 $71,754 - $159,686
-19,033 Reduced 3.03%
609,905 $4.87 Million
Q3 2023

Nov 14, 2023

SELL
$5.2 - $8.77 $52,000 - $87,700
-10,000 Reduced 1.57%
628,938 $4.08 Million
Q2 2023

Aug 14, 2023

BUY
$5.86 - $7.93 $272,490 - $368,745
46,500 Added 7.85%
638,938 $3.84 Million
Q1 2023

May 15, 2023

BUY
$5.85 - $9.84 $351,000 - $590,400
60,000 Added 11.27%
592,438 $3.67 Million
Q3 2022

Nov 14, 2022

SELL
$8.19 - $13.2 $163,800 - $264,000
-20,000 Reduced 3.62%
532,438 $5.04 Million
Q2 2022

Aug 15, 2022

BUY
$7.65 - $14.24 $1.99 Million - $3.7 Million
259,691 Added 88.71%
552,438 $5.61 Million
Q1 2022

May 16, 2022

BUY
$13.02 - $20.78 $1.79 Million - $2.86 Million
137,500 Added 88.57%
292,747 $4.17 Million
Q4 2021

Feb 14, 2022

BUY
$19.35 - $25.54 $925,607 - $1.22 Million
47,835 Added 44.53%
155,247 $3.21 Million
Q3 2021

Nov 15, 2021

BUY
$21.65 - $39.49 $2.33 Million - $4.24 Million
107,412 New
107,412 $2.45 Million
Q2 2021

Aug 16, 2021

SELL
$15.5 - $22.48 $1.98 Million - $2.87 Million
-127,500 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$9.4 - $16.7 $117,500 - $208,750
-12,500 Reduced 8.93%
127,500 $1.93 Million
Q2 2020

Aug 14, 2020

SELL
$21.87 - $33.11 $328,050 - $496,650
-15,000 Reduced 9.68%
140,000 $3.42 Million
Q1 2020

May 15, 2020

BUY
$16.25 - $35.28 $162,500 - $352,800
10,000 Added 6.9%
155,000 $3.74 Million
Q3 2019

Nov 14, 2019

BUY
$14.42 - $22.2 $1.76 Million - $2.7 Million
121,834 Added 525.92%
145,000 $2.09 Million
Q2 2019

Aug 14, 2019

SELL
$16.26 - $26.42 $421,085 - $684,198
-25,897 Reduced 52.78%
23,166 $440,000
Q1 2019

May 15, 2019

BUY
$15.97 - $22.5 $783,536 - $1.1 Million
49,063 New
49,063 $918,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $386M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.